EBCC-14 manifesto: Addressing disparities in access to innovation for patients with metastatic breast cancer across Europe

Michail Ignatiadis; Fiorita Poulakaki; Tanja Spanic; Etienne Brain; Denis Lacombe; Gabe S. Sonke; Anne Vincent-Salomon; Frederieke Van Duijnhoven; Icro Meattini; Orit Kaidar-Person; Philippe Aftimos; Frederic Lecouvet; Fatima Cardoso; Valesca P. Retèl; David Cameron

doi:10.1016/j.ejca.2024.114156

EBCC-14 manifesto: Addressing disparities in access to innovation for patients with metastatic breast cancer across Europe

Michail Ignatiadis^*, Fiorita Poulakaki, Tanja Spanic, Etienne Brain, Denis Lacombe, Gabe S. Sonke, Anne Vincent-Salomon, Frederieke Van Duijnhoven, Icro Meattini, Orit Kaidar-Person, Philippe Aftimos, Frederic Lecouvet, Fatima Cardoso, Valesca P. Retèl, David Cameron

^*Corresponding author for this work

Health Technology Assessment (HTA)

Research output: Contribution to journal › Review article › Academic › peer-review

16 Downloads (Pure)

Abstract

The European Breast Cancer Council (EBCC) traditionally identifies controversies or major deficiencies in the management of patients with breast cancer and selects a multidisciplinary expert team to collaborate in setting crucial principles and recommendations to improve breast cancer care. The 2024 EBCC manifesto focuses on disparities in the care of patients with metastatic breast cancer. There are several reasons for existing disparities both between and within countries. Our recommendations aim to address the stigma of metastatic disease, which has led to significant disparities in access to innovative care regardless of the gross national income of a country. These recommendations are for different stakeholders to promote the care of patients with metastatic breast cancer across Europe and worldwide.

Original language	English
Article number	114156
Journal	European Journal of Cancer
Volume	207
DOIs	https://doi.org/10.1016/j.ejca.2024.114156
Publication status	Published - Aug 2024

Bibliographical note

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.ejca.2024.114156

1-s2.0-S0959804924008128-mainFinal published version, 675 KBLicence: CC BY-NC-ND

Cite this

Ignatiadis, M., Poulakaki, F., Spanic, T., Brain, E., Lacombe, D., Sonke, G. S., Vincent-Salomon, A., Van Duijnhoven, F., Meattini, I., Kaidar-Person, O., Aftimos, P., Lecouvet, F., Cardoso, F., Retèl, V. P., & Cameron, D. (2024). EBCC-14 manifesto: Addressing disparities in access to innovation for patients with metastatic breast cancer across Europe. European Journal of Cancer, 207, Article 114156. https://doi.org/10.1016/j.ejca.2024.114156

@article{2fe296d472cb42dab7d047c99f8fff5e,

title = "EBCC-14 manifesto: Addressing disparities in access to innovation for patients with metastatic breast cancer across Europe",

abstract = "The European Breast Cancer Council (EBCC) traditionally identifies controversies or major deficiencies in the management of patients with breast cancer and selects a multidisciplinary expert team to collaborate in setting crucial principles and recommendations to improve breast cancer care. The 2024 EBCC manifesto focuses on disparities in the care of patients with metastatic breast cancer. There are several reasons for existing disparities both between and within countries. Our recommendations aim to address the stigma of metastatic disease, which has led to significant disparities in access to innovative care regardless of the gross national income of a country. These recommendations are for different stakeholders to promote the care of patients with metastatic breast cancer across Europe and worldwide.",

author = "Michail Ignatiadis and Fiorita Poulakaki and Tanja Spanic and Etienne Brain and Denis Lacombe and Sonke, {Gabe S.} and Anne Vincent-Salomon and {Van Duijnhoven}, Frederieke and Icro Meattini and Orit Kaidar-Person and Philippe Aftimos and Frederic Lecouvet and Fatima Cardoso and Ret{\`e}l, {Valesca P.} and David Cameron",

note = "Publisher Copyright: {\textcopyright} 2024",

year = "2024",

month = aug,

doi = "10.1016/j.ejca.2024.114156",

language = "English",

volume = "207",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Ltd.",

}

Ignatiadis, M, Poulakaki, F, Spanic, T, Brain, E, Lacombe, D, Sonke, GS, Vincent-Salomon, A, Van Duijnhoven, F, Meattini, I, Kaidar-Person, O, Aftimos, P, Lecouvet, F, Cardoso, F, Retèl, VP & Cameron, D 2024, 'EBCC-14 manifesto: Addressing disparities in access to innovation for patients with metastatic breast cancer across Europe', European Journal of Cancer, vol. 207, 114156. https://doi.org/10.1016/j.ejca.2024.114156

TY - JOUR

T1 - EBCC-14 manifesto

T2 - Addressing disparities in access to innovation for patients with metastatic breast cancer across Europe

AU - Ignatiadis, Michail

AU - Poulakaki, Fiorita

AU - Spanic, Tanja

AU - Brain, Etienne

AU - Lacombe, Denis

AU - Sonke, Gabe S.

AU - Vincent-Salomon, Anne

AU - Van Duijnhoven, Frederieke

AU - Meattini, Icro

AU - Kaidar-Person, Orit

AU - Aftimos, Philippe

AU - Lecouvet, Frederic

AU - Cardoso, Fatima

AU - Retèl, Valesca P.

AU - Cameron, David

PY - 2024/8

Y1 - 2024/8

N2 - The European Breast Cancer Council (EBCC) traditionally identifies controversies or major deficiencies in the management of patients with breast cancer and selects a multidisciplinary expert team to collaborate in setting crucial principles and recommendations to improve breast cancer care. The 2024 EBCC manifesto focuses on disparities in the care of patients with metastatic breast cancer. There are several reasons for existing disparities both between and within countries. Our recommendations aim to address the stigma of metastatic disease, which has led to significant disparities in access to innovative care regardless of the gross national income of a country. These recommendations are for different stakeholders to promote the care of patients with metastatic breast cancer across Europe and worldwide.

AB - The European Breast Cancer Council (EBCC) traditionally identifies controversies or major deficiencies in the management of patients with breast cancer and selects a multidisciplinary expert team to collaborate in setting crucial principles and recommendations to improve breast cancer care. The 2024 EBCC manifesto focuses on disparities in the care of patients with metastatic breast cancer. There are several reasons for existing disparities both between and within countries. Our recommendations aim to address the stigma of metastatic disease, which has led to significant disparities in access to innovative care regardless of the gross national income of a country. These recommendations are for different stakeholders to promote the care of patients with metastatic breast cancer across Europe and worldwide.

UR - http://www.scopus.com/inward/record.url?scp=85195440341&partnerID=8YFLogxK

U2 - 10.1016/j.ejca.2024.114156

DO - 10.1016/j.ejca.2024.114156

M3 - Review article

C2 - 38861756

AN - SCOPUS:85195440341

SN - 0959-8049

VL - 207

JO - European Journal of Cancer

JF - European Journal of Cancer

M1 - 114156

ER -

EBCC-14 manifesto: Addressing disparities in access to innovation for patients with metastatic breast cancer across Europe

Abstract

Bibliographical note

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this